Targeting Tumors Using Nanoparticle Platforms: A Phase I Study of a Systemically Administered Gene Therapy System

This publication has 15 references indexed in Scilit:

• Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors
  Molecular Therapy, 2013
• P53 abnormalities and outcomes in colorectal cancer: a systematic review
  British Journal of Cancer, 2005
• Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide
  Nucleic Acids Research, 2004
• In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy
  Pharmaceutical Research, 2002
• Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.
  2002
• Self-Assembly of a Virus-Mimicking Nanostructure System for Efficient Tumor-Targeted Gene Delivery
  Human Gene Therapy, 2002
• Precision-Cut Organ Slices as a Tool to Study Toxicity and Metabolism of Xenobiotics with Special Reference to Non-Hepatic Tissues
  Current Drug Metabolism, 2002
• Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy
  Journal of Controlled Release, 2001
• Parenteral Gene Therapy with p53 Inhibits Human Breast Tumors In Vivo Through a Bystander Mechanism Without Evidence of Toxicity
  Human Gene Therapy, 1997
• Thep53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers
  Journal of Cancer Research and Clinical Oncology, 1996